Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine

Clinical and Vaccine Immunology

Volumn 20, Issue 2, 2013, Pages 227-238

  Erova, Tatiana E ^a   Rosenzweig, Jason A ^b   Sha, Jian ^a,c   Suarez, Giovanni ^a   Sierra, Johanna C ^a   Kirtley, Michelle L ^a   Van Lier, Christina J ^a   Telepnev, Maxim V ^a   Motin, Vladimir L ^a,c   Chopra, Ashok K ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTACHMENT INVASION LOCUS PROTEIN; ATTACHMENT INVASION LOCUS PROTEIN ANTIBODY; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; LEVOFLOXACIN; MUTANT PROTEIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN A; OUTER MEMBRANE PROTEIN A ANTIBODY; PLAGUE VACCINE; PLASMINOGEN ACTIVATING PROTEASE; PROTEIN ANTIBODY; PROTEIN F1; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG SCREENING; ESCHERICHIA COLI; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MASS SPECTROMETRY; MOLECULAR CLONING; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PURIFICATION; RAT; SERUM; VACCINE PRODUCTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; IMMUNE SERA; IMMUNIZATION; IMMUNIZATION, PASSIVE; MICE; OFLOXACIN; PLAGUE; PLAGUE VACCINE; PLASMINOGEN ACTIVATORS; RATS; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC; VIRULENCE FACTORS; YERSINIA PESTIS;

EID: 84874837967     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00597-12     Document Type: Article

References (50)

1. Ligon BL. 2006. Plague: a review of its history and potential as a biological weapon. Semin. Pediatr. Infect. Dis. 17:161-170.
2. Chain PS, Carniel E, Larimer FW, Lamerdin J, Stoutland PO, Regala WM, Georgescu AM, Vergez LM, Land ML, Motin VL, Brubaker RR, Fowler J, Hinnebusch J, Marceau M, Medigue C, Simonet M, Chenal-Francisque V, Souza B, Dacheux D, Elliott JM, Derbise A, Hauser LJ, Garcia E. 2004. Insights into the evolution of Yersinia pestis through whole genome comparison with Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. U. S. A. 101:13826-13831.
3. Rosenzweig JA, Jejelowo O, Sha J, Erova TE, Brackman SM, Kirtley ML, van Lier CJ, Chopra AK. 2011. Progress on plague vaccine development. Appl. Microbiol. Biotechnol. 91:265-286.
4. Quenee LE, Berube BJ, Segal J, Elli D, Ciletti NA, Anderson D, Schneewind O. 2010. Amino acid residues 196-225 of LcrV represent a plague protective epitope. Vaccine 28:1870-1876.
5. Qiu Y, Liu Y, Qi Z, Wang W, Kou Z, Zhang Q, Liu G, Liu T, Yang Y, Yang X, Xin Y, Li C, Cui B, Huang S, Liu H, Zeng L, Wang Z, Yang R, Wang H, Wang X. 2010. Comparison of immunological responses of plague vaccines F1 + rV270 and EV76 in Chinese-origin rhesus macaque, Macaca mulatta. Scand. J. Immunol. 72:425-433.
6. Chichester JA, Musiychuk K, Farrance CE, Mett V, Lyons J, Mett V, Yusibov Y. 2009. A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague. Vaccine 27:3471-3474.
7. Smiley ST. 2008. Current challenges in the development of vaccines for pneumonic plague. Expert Rev. Vaccines 7:209-221.
8. Titball RW, Williamson ED. 2004. Yersinia pestis (plague) vaccines. Expert. Opin. Biol. Ther. 4:965-973.
9. Anderson GW, Jr, Leary SE, Williamson ED, Titball RW, Welkos SL, Worsham PL, Friedlander AM. 1996. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsulepositive and -negative strains of Yersinia pestis Infect. Immun. 64:4580-4585.
10. Friedlander AM, Welkos SL, Worsham PL, Andrews GP, Heath DG, Anderson GW, Jr, Pitt ML, Estep J, Davis K. 1995. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21:S178-S181.
11. Anderson GW, Jr, Heath DG, Bolt CR, Welkos SL, Friedlander AM. 1998. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58:793-799.
12. Heath DG, Anderson GW, Jr, Mauro JM, Welkos SL, Andrews GP, Adamovicz J, Friedlander AM. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131-1137.
13. Branger CG, Sun W, Torres-Escobar A, Perry R, Roland KL, Fetherston J, Curtiss R, III. 2010. Evaluation of Psn, HmuR, and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge. Vaccine 29:274-282.
14. Sun W, Curtiss R, III. 2012. Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis. Microb. Pathog. 53:198-206.
15. Hinnebusch BJ, Fischer ER, Schwan TG. 1998. Evaluation of the role of the Yersinia pestis plasminogen activator and other plasmid-encoded factors in temperature-dependent blockage of the flea. J. Infect. Dis. 178: 1406-1415.
16. Hinnebusch BJ, Jarrett CO, Callison JA, Gardner D, Buchanan SK, Plano GV. 2011. Role of the Yersinia pestis Ail protein in preventing a protective polymorphonuclear leukocyte response during bubonic plague. Infect. Immun. 79:4984-4989.
17. Weening EH, Cathelyn JS, Kaufman G, Lawrenz MB, Price P, Goldman WE, Miller VL. 2011. The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background. Infect. Immun. 79: 644-652.
18. Kukkonen M, Korhonen TK. 2004. The omptin family of enterobacterial surface proteases/adhesins: from housekeeping in Escherichia coli to systemic spread of Yersinia pestis. Int. J. Med. Microbiol. 294:7-14.
19. Lobo LA. 2006. Adhesive properties of the purified plasminogen activator Pla of Yersinia pestis. FEMS Microbiol. Lett. 262:158-162.
20. Saksela O. 1985. Plasminogen activation and regulation of pericellular proteolysis. Biochim. Biophys. Acta 823:35-65.
21. 2-antiplasmin in the surface protease Pla of Yersinia pestis. Mol. Microbiol. 40:1097-1111.
22. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. 1992. A surface protease and the invasive character of plague. Science 258:1004-1007.
23. Sodeinde OA, Sample AK, Brubaker RR, Goguen JD. 1988. Plasminogen activator/coagulase gene of Yersinia pestis is responsible for degradation of plasmid-encoded outer membrane proteins. Infect. Immun. 56:2749-2752.
24. Kukkonen M, Suomalainen M, Kyllonen P, Lahteenmaki K, Lang H, Virkola R, Helander IM, Holst O, Korhonen TK. 2004. Lack of O-antigen is essential for plasminogen activation by Yersinia pestis and Salmonella enterica. Mol. Microbiol. 51:215-225.
25. Bartra SS, Styer KL, O'Bryant DM, Nilles ML, Hinnebusch BJ, Aballay A, Plano GV. 2008. Resistance of Yersinia pestis to complementdependent killing is mediated by the Ail outer membrane protein. Infect. Immun. 76:612-622.
26. Felek S, Krukonis ES. 2009. The Yersinia pestis Ail protein mediates binding and Yop delivery to host cells required for plague virulence. Infect. Immun. 77:825-836.
27. Kolodziejek AM, Schnider DR, Rohde HN, Wojtowicz AJ, Bohach GA, Minnich SA, Hovde CJ. 2010. Outer membrane protein X (Ail) contributes to Yersinia pestis virulence in pneumonic plague and its activity is dependent on the lipopolysaccharide core length. Infect. Immun. 78: 5233-5243.
28. Felek S, Tsang TM, Krukonis ES. 2010. Three Yersinia pestis adhesins facilitate Yop delivery to eukaryotic cells and contribute to plague virulence. Infect. Immun. 78:4134-4150.
29. Tsang TM, Felek S, Krukonis ES. 2010. Ail binding to fibronectin facilitates Yersinia pestis binding to host cells and Yop delivery. Infect. Immun. 78:3358-3368.
30. Park JS, Lee WC, Yeo KJ, Ryu KS, Kumarasiri M, Hesek D, Lee M, Mobashery S, Song JH, Kim SI, Lee JC, Cheong C, Jeon YH, Kim HY. 2012. Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane. FASEB J. 26: 219-228.
31. Sugawara E, Nikaido H. 1992. Pore-forming activity of OmpA protein of Escherichia coli. J. Biol. Chem. 267:2507-2511.
32. Fu H, Belaaouaj AA, Dahlgren C, Bylund J. 2003. Outer membrane protein A-deficient Escherichia coli activates neutrophils to produce superoxide and shows increased susceptibility to antibacterial peptides. Microbes Infect. 5:781-788.
33. Llobet E, March C, Giménez P, Bengoechea JA. 2009. Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides. Antimicrob. Agents Chemother. 53:298-302.
34. Prasadarao NV, Wass CA, Weiser JN, Stins MF, Huang SH, Kim KS. 1996. Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect. Immun. 64:146-153.
35. Bartra SS, Gong X, Lorica CD, Jain C, Nair MK, Schifferli D, Qian L, Li Z, Plano GV, Schesser K. 2011. The outer membrane protein A (OmpA) of Yersinia pestis promotes intracellular survival and virulence in mice. Microb. Pathog. 52:41-46.
36. Erova TE, Pillai L, Fadl AA, Sha J, Wang S, Galindo AK, Chopra CL. 2006.DNAadenine methyltransferase influences the virulence of Aeromonas hydrophila. Infect. Immun. 74:410-424.
37. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
38. Agarkov A, Chauhan S, Lory PJ, Gilbertson SR, Motin VL. 2008. Substrate specificity and screening of the integral membrane protease Pla. Bioorg. Med. Chem. Lett. 18:427-431.
39. Sha J, Endsley JJ, Kirtley ML, Foltz SM, Huante MB, Erova TE, Kozlova EV, Popov VL, Yeager LA, Zudina IV, Motin VL, Peterson JW, DeBord KL, Chopra AK. 2011. Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks. J. Clin. Microbiol. 49:1708-1715.
40. Sha J, Pillai L, Fadl AA, Galindo CL, Erova TE, Chopra AK. 2005. The type III secretion system and cytotoxic enterotoxin alter the virulence of Aeromonas hydrophila. Infect. Immun. 73:6446-6457.
41. Zavialov AV, Knight SD. 2007. A novel self-capping mechanism controls aggregation of periplasmic chaperone Caf1M. Mol. Microbiol. 64:153-164.
42. Agar SL, Sha J, Foltz SM, Erova TE, Walberg KG, Parham TE, Baze WB, Suarez G, Peterson JW, Chopra AK. 2008. Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Microbiology 154:1939-1948.
43. Agar SL, Sha J, Foltz SM, Erova TE, Walberg KG, Parham TE, Baze WB, Suarez G, Peterson JW, Chopra AK. 2009. Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92. Microbes Infect. 11:205-214.
44. Anisimov AP, Dentovskaya SV, Panfertsev EA, Svetoch TE, Kopylov PK, Segelke BW, Zemla A, Telepnev MV, Motin VL. 2010. Amino acid and structural variability of Yersinia pestis LcrV protein. Infect. Genet. Evol. 10:137-145.
45. Friedlander AM, Welkos SL, Worsham PL, Andrews GP, Heath DG, Anderson GW, Jr, Pitt ML, Estep J, Davis K. 1995. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21:178-181.
46. Davis KJ, Fritz DL, Pitt ML, Welkos SL, Worsham PL, Friedlander AM. 1996. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch. Pathol. Lab. Med. 120:156-163.
47. Williamson ED, Packer PJ, Waters EL, Simpson AJ, Dyer D, Hartings J, Twenhafel N, Pitt MLM. 2011. Recombinant (F1 + V) vaccine protects cynomolgus macaques against pneumonic plague. Vaccine 29:4771-4777.
48. Anderson GW, Jr, Worsham PL, Bolt CR, Andrews GP, Welkos SL, Friedlander AM, Burans JP. 1997. Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis. Am. J. Trop. Med. Hyg. 56:471-473.
49. Turner JK, McAllister MM, Xu JL, Tapping RI. 2008. The resistance of BALB/cJ mice to Yersinia pestis maps to the major histocompatibility complex of chromosome 17. Infect. Immun. 76:4092-4099.
50. Smiley ST. 2008. Immune defense against pneumonic plague. Immunol. Rev. 225:256-271.